Association between mode of birth and incidence of inhibitor in Hemophilia A PUPs (FVIII <2%)

Progress

Inclusions closed on 02/09/2021
Analysis in progress

Presentation and objectives

To investigate an association between the occurrence of an anti-FVIII inhibitor and the mode of birth, vaginal or caesarean, in haemophilia A patients of the FranceCoag PUPs subcohort.

Persons concerned
Type of data collected
(*data excluding FranceCoag)

Male members of FranceCoag’s PUPs cohort with hemophilia A (Factor VIII level < 2%) and born since 01/01/2000

Methods of birth

Regulatory approvals
Information note

Favourable opinion from FranceCoag’s Scientific Committee
MR004 declared to the CNIL

NI Patients and Parents

Project sponsor (financier)

Dr Hortense Maynadié, and Dr Roseline D’Oiron (CRH Bicêtre)